The Radiopharmaceutical Theranostics Market segment includes beta-emitting and alpha-emitting therapeutic agents, PET and SPECT imaging agents, and radiolabeled antibodies for targeted therapy. Hospitals, oncology centers, and research institutions use these agents for diagnostic and therapeutic purposes. Segment analysis provides insights into high-demand products, application areas, and...